SurgePays (NASDAQ:SURG – Get Free Report) is anticipated to announce its Q4 2025 results after the market closes on Tuesday, March 31st. Analysts expect the company to announce earnings of ($0.23) per share and revenue of $21.1560 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, April 10, 2026 at 4:00 PM ET.
SurgePays Price Performance
SURG stock opened at $0.74 on Monday. The company has a current ratio of 0.52, a quick ratio of 0.41 and a debt-to-equity ratio of 101.87. The firm has a 50-day moving average of $0.97 and a two-hundred day moving average of $1.81. SurgePays has a 12 month low of $0.73 and a 12 month high of $3.47. The company has a market cap of $17.35 million, a price-to-earnings ratio of -0.35 and a beta of 0.50.
Analysts Set New Price Targets
SURG has been the subject of several recent research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SurgePays in a report on Monday, December 29th. Ascendiant Capital Markets boosted their price objective on SurgePays from $9.50 to $9.75 and gave the stock a “buy” rating in a research note on Monday, December 22nd. Wall Street Zen upgraded SurgePays to a “sell” rating in a report on Saturday, January 3rd. Finally, Zacks Research raised SurgePays from a “strong sell” rating to a “hold” rating in a research note on Monday, February 23rd. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, SurgePays presently has a consensus rating of “Hold” and an average price target of $9.75.
Institutional Trading of SurgePays
Several institutional investors have recently made changes to their positions in the company. Jones Financial Companies Lllp lifted its holdings in SurgePays by 34,091.3% in the first quarter. Jones Financial Companies Lllp now owns 51,287 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 51,137 shares during the last quarter. Goldman Sachs Group Inc. acquired a new stake in SurgePays during the first quarter worth $28,000. Cetera Investment Advisers raised its position in SurgePays by 61.0% in the second quarter. Cetera Investment Advisers now owns 45,400 shares of the medical equipment provider’s stock valued at $141,000 after purchasing an additional 17,200 shares during the period. XTX Topco Ltd acquired a new position in shares of SurgePays in the 2nd quarter valued at $125,000. Finally, NewEdge Advisors LLC lifted its stake in shares of SurgePays by 46.2% in the 2nd quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 6,000 shares during the last quarter. Hedge funds and other institutional investors own 6.94% of the company’s stock.
SurgePays Company Profile
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Recommended Stories
Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.
